EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Relationship between kisspeptin levels in the third trimester and late-onset fetal growth restriction: A case-control study

Mujde Can Ibanoglu, Z Asli Oskovi-Kaplan, Ozgur Kara, A Seval Ozgu-Erdinc, Dilek Şahin

Placenta · 2023

DOI: 10.1016/j.placenta.2023.07.012 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Placenta, 2023. Verfasst von Mujde Can Ibanoglu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Etlik Zubeyde Hanim Women's Health Education of Research Hospital, Department of Obstetrics and Gynecology, Turkey. Electronic address: drmujdecan@gm…. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Kisspeptins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: We aimed to investigate whether maternal serum kisspeptin levels are associated with late-onset FGR and contribute to adverse perinatal outcomes. METHOD: In this case-control study, a total of 90 pregnant women admitted to the perinatology clinic were enrolled. Forty-five of them were diagnosed with FGR and 45 women with healthy pregnancies formed the control group. Maternal serum levels of kisspeptin 1 were compared. RESULTS: Median kisspeptin1 serum levels were higher in the group of patients with FGR according to gestational age than in the control group [79.4(3.9-230.2) pg/mL vs. 39.8(0.4-188.3) pg/mL; p = 0.001]. The optimal cut-off value for kisspeptin1 was 30.32 pg/mL, with a positive predictive value of 64.6% (95% CI; 0.54-0.86), negative predictive value of 87.5% (95% CI; 0.44-0.72), positive likelihood ratio 1.75 (95% CI; 1.31-2.32), negative likelihood ratio 0.14 (95% CI; 0.04-0.44). DISCUSSION: Kisspeptin1 differed significantly in late-onset FGR compared with the control group. This difference from the control group can be used to estimate late-onset FGR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal Growth RetardationKisspeptinsPregnancyFemaleHumansInfant, NewbornPregnancy Trimester, ThirdCase-Control StudiesInfant, Small for Gestational AgeGestational AgeUltrasonography, Prenatal

Stichwörter der Autor:innen

Growth restrictionKisspeptinPlacental insufficiency

Substanzen

Kisspeptins

Autor:innen und Institutionen

  • Etlik Zubeyde Hanim Women's Health Education of Research Hospital, Department of Obstetrics and Gynecology, Turkey. Electronic address: drmujdecan@gmail.com.
  • Ministry of Health Ankara City Hospital, Department of Obstetrics and Gynecology, Turkey.
  • Ministry of Health Ankara City Hospital, Department of Perinatology, Turkey.

Zitieren

APA

Ibanoglu, M. C., Oskovi-Kaplan, Z. A., Kara, O., Ozgu-Erdinc, A. S., & Şahin, D. (2023). Relationship between kisspeptin levels in the third trimester and late-onset fetal growth restriction: A case-control study. Placenta. https://doi.org/10.1016/j.placenta.2023.07.012

Vancouver

Ibanoglu MC, Oskovi-Kaplan ZA, Kara O, Ozgu-Erdinc AS, Şahin D. Relationship between kisspeptin levels in the third trimester and late-onset fetal growth restriction: A case-control study. Placenta. 2023. doi:10.1016/j.placenta.2023.07.012

BibTeX
@article{Ibanoglu2023,
  author = {Ibanoglu, Mujde Can and Oskovi-Kaplan, Z Asli and Kara, Ozgur and Ozgu-Erdinc, A Seval and Şahin, Dilek},
  title = {Relationship between kisspeptin levels in the third trimester and late-onset fetal growth restriction: A case-control study},
  journal = {Placenta},
  year = {2023},
  doi = {10.1016/j.placenta.2023.07.012}
}
Kostenlos starten →